Remote Liquid Oncology Product Manager
Caris Life Sciences, Ltd.
Turn this role into an interview — a resume and cover letter built around what this employer wants.
Job summary
Caris Life Sciences, Ltd. is seeking a Liquid Product Manager to oversee liquid oncology product development and commercialization, ensuring high adoption of our liquid offerings.
The role collaborates with commercial teams on all stages from development to launch and market adoption, focusing on regulatory compliance and market readiness. The candidate will bring 5–7 years in molecular diagnostics, with strong knowledge of oncology therapeutics and biomarkers, and will travel up to 75% to
Qualifications
- 5-7 years of experience within molecular diagnostics or relevant industry.
- Strong knowledge of oncology therapeutics, surgical oncology intervention and molecular laboratory science.
- Working knowledge of oncology biomarkers and associated drug response.
Responsibilities
- Manage a product roadmap from concept to commercial adoption, partnering with local commercial teams on all stages of product adoption.
- Deliver the operating plan to achieve growth objectives.
- Identify, collaborate, and build a strategy tailored to specific customer and company needs.
- Collaborate across business units on go‑to‑market strategies and ensure end-to-end execution.
- Engage in a consultative advisory role with client partners on technology‑based solutions.
- Provide business solutions to large hospital systems, GPO/IDN and other relevant customers.
- Develop and maintain relationships with new and existing clients within the Liquid Product Market.
- Provide post‑sales service and explore additional business opportunities.
- Travel 75% of time to meet clients and prospects.
Skills
Education
Job description
Caris Life Sciences, Ltd. is seeking a Liquid Product Manager to oversee liquid oncology product development and commercialization, ensuring high adoption of our liquid offerings.
The role collaborates with commercial teams on all stages from development to launch and market adoption, focusing on regulatory compliance and market readiness. The candidate will bring 5–7 years in molecular diagnostics, with strong knowledge of oncology therapeutics and biomarkers, and will travel up to 75% to
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
